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We have previously shown that elevating extracellular calcium from a concentration of 1.8 to 8 mM accelerates
and increases human adipose-derived stem cell (hASC) osteogenic differentiation and cell-mediated calcium
accretion, even in the absence of any other soluble osteogenic factors in the culture medium. However, the
effects of elevated calcium on hASC chondrogenic differentiation have not been reported. The goal of this study
was to determine the effects of varied calcium concentrations on chondrogenic differentiation of hASC. We
hypothesized that exposure to elevated extracellular calcium (8 mM concentration) in a chondrogenic differ-
entiation medium (CDM) would inhibit chondrogenesis of hASC when compared to basal calcium (1.8 mM
concentration) controls. We further hypothesized that a full osteochondral construct could be engineered by
controlling local release of calcium to induce site-specific chondrogenesis and osteogenesis using only hASC as
the cell source. Human ASC was cultured as micromass pellets in CDM containing transforming growth factor-
b1 and bone morphogenetic protein 6 for 28 days at extracellular calcium concentrations of either 1.8 mM
(basal) or 8 mM (elevated). Our findings indicated that elevated calcium induced osteogenesis and inhibited
chondrogenesis in hASC. Based on these findings, stacked polylactic acid nanofibrous scaffolds containing
either 0% or 20% tricalcium phosphate (TCP) nanoparticles were electrospun and tested for site-specific
chondrogenesis and osteogenesis. Histological assays confirmed that human ASC differentiated locally to
generate calcified tissue in layers containing 20% TCP, and cartilage in the layers with no TCP when cultured in
CDM. This is the first study to report the effects of elevated calcium on chondrogenic differentiation of hASC,
and to develop osteochondral nanofibrous scaffolds using a single cell source and controlled calcium release to
induce site-specific differentiation. This approach holds great promise for osteochondral tissue engineering
using a single cell source (hASC) and single scaffold.
Introduction
Calcium is a critical ion in cell biology that plays akey role in a number of cell functions necessary for cell
homeostasis. Important cell functions are often directed by
the transport of calcium (Ca2 + ) across the cell membrane,
into the cytoplasm from intracellular stores, or the allosteric
binding of Ca2 + to a protein.1,2 Calcium can act as a second
messenger translating mechanical load to a chemical signal
directing cell activity, as with certain stretch-activated me-
chanotransducers.2–4 It can further act as a first messenger,
binding with proteins outside of cell membranes, causing a
cascade of signals within the cell.5
Elevated Ca2 + has been shown to affect cell differen-
tiation in various cell types. It has been reported that in-
creasing the extracellular Ca2 + levels from 0.03 to 1.2 mM
leads to increased intracellular Ca2 + as well as the pro-
duction of differentiation-related genes in keratinocytes.6
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Elevating extracellular Ca2 + to 2.5 mM has been shown
effective in diminishing adipogenic differentiation, as evi-
denced by decreased cytoplasmic lipids, and downregulating
the gene expression of adipogenic markers in 3T3-L1 pre-
adipocytes.7 It has also been reported that elevated Ca2 + is
effective in directing osteogenic lineage specification of
dental pulp cells. Ca2 + concentrations from 1.8 to 16.2 mM
were analyzed, and it was found that higher concentrations
increased matrix mineralization, without a significant im-
pact on cell proliferation.8
We have previously reported the effects of three different
calcium concentrations (1.8, 8, and 16 mM) on hASC os-
teogenesis for hASC in 2D monolayer culture maintained in
a complete growth medium (CGM) or osteogenic differen-
tiation medium,9 and in electrospun scaffolds containing
different concentrations of tricalcium phosphate (TCP).10
We showed that exposure to 8 mM Ca2 + concentration re-
sulted in the greatest hASC osteogenesis and cell-mediated
calcium accretion; these effects were significantly decreased
at 16 mM Ca2 + concentration. These findings are consistent
with previous studies showing that ionic calcium levels
between 6 and 10 mM significantly increased osteoblast
mineralization, whereas concentrations above 10 mM can be
cytotoxic.11
However, elevated Ca2 + has been found to be detrimental
for chondrocyte growth and proliferation. Previous investi-
gators have shown the impact of extracellular Ca2 + in chon-
drocyte death within damaged cartilage tissue.12 For example,
damaged cartilage that was cultured in Ca2 + -free medium
showed significantly lower cell death after 2.5 h than tissue
cultured in Ca2 + -rich media (2–20 mM). Increasing Ca2 +
resulted in increased cell death, all within the superficial zone
of the cartilage tissue. However, at day 7, greater cell death
occurred in the deep zone of the cartilage tissue cultured in
Ca2 + -free medium relative to samples cultured in Ca2 + -rich
medium,12 further demonstrating the effects of Ca2 + on car-
tilage tissue viability, and the varied response within different
layers of articular cartilage to Ca2 + concentrations.
Human adipose-derived stem cells (hASC) provide an
abundant and easily accessible source of cells for tissue
engineering,13 and previous studies have shown the ability
of these cells to differentiate into osteogenic or chondro-
genic lineages under appropriate culture conditions.10,14,15
Our laboratory has previously published the effects of ele-
vating Ca2 + levels on hASC osteogenesis, in both complete
growth and osteogenic differentiation media, comparing
mineralization and proliferation.9,10,16 The use of elevated
Ca2 + to direct hASC osteogenic lineage specification is a
clear advantage in bone tissue engineering. However, the
impact of elevated Ca2 + has not been widely studied in
chondrogenic differentiation of hASC and cartilage tissue
engineering. The ability to influence osteogenic or chon-
drogenic differentiation through modulation of extracellular
Ca2 + may provide a novel means of inducing osteochondral
regeneration using a single cell source and single scaffold.
Therefore, the purpose of this study was to determine
the effects of elevated Ca2 + on combined osteogenic and
chondrogenic differentiation of hASC. Our experimental
approach was to compare chondrogenic factors in hASC
treated with elevated (8 mM) or basal (1.8 mM) Ca2 + con-
centrations. We hypothesized that 8 mM Ca2 + would inhibit
hASC chondrogenesis relative to 1.8 mM Ca2 + and induce a
differentiation phenotype representing a combination of
both hASC osteogenesis and chondrogenesis. We then used
a similar approach to investigate the potential of using
elevated Ca2 + to develop osteochondral constructs using a
multilayer nanofibrous construct developed by our labora-
tory 10,17 capable of delivering varied Ca2 + concentrations.
The multilayered construct was composed of electrospun
polylactic acid (PLA) nanofibrous scaffolds bound together
through polymerization of type I collagen gel.11
For this study, we developed a five-layer scaffold com-
posed of three pure PLA nanofibrous layers within the upper
region where cartilage generation was desired and two
layers containing 20 wt% TCP nanoparticles within the
bottom region where bone generation was desired. We have
previously shown that these TCP/PLA composite nanofibers
will release Ca2 + and promote the osteogenic differentiation
of hASCs.10,16 We hypothesized that the five-layer scaffolds
composed of two distinct but integrated layers of nanofibers
would promote site-specific hASC chondrogenic and oste-
ogenic differentiation to create cartilaginous and bone-like
tissues in one construct.
Although previous studies have used a single stem cell
source to develop osteochondral tissue,18–26 the approaches
usually involve local delivery of growth factors through
microspheres to the different layers,19 or complex fabrica-
tion of multiphasic scaffolds using different materials or
composites to resemble the different architectures of the
native osteochondral tissue,18,22,23 or used a combination of
osteogenic (beta-glycerophosphate) and chondrogenic (in-
sulin) factors within the scaffold,24 complex double-chamber
bioreactors,25,27 or complex integrated scaffolds.26 Graded
TCP electrospun scaffolds have also been used with mouse
preosteoblast cells (MC3T3-E1) to induce continuous
mineralized tissue representative of the bone–cartilage in-
terface, but not cartilage tissue.28 Our study uses a simple
calcium gradient scaffold approach to simultaneously modu-
late both osteogenesis and chondrogenesis of human adipose-
derived stem cells without the need of bioreactors or dif-
ferent types of media. This approach is novel and provides a
facile and translatable approach for osteochondral tissue
engineering using abundant and accessible adipose-derived
stem cells.
Materials and Methods
Isolation and culture of hASC
Excess adipose tissue was obtained from five premeno-
pausal donors (24- to 36-year-old females, three Caucasian,
one Native American, and one of unknown ethnicity) in
accordance with an approved IRB protocol at UNC Chapel
Hill (IRB 04-1622) and as described previously by our
laboratory.15 Human ASCs were isolated from the tissue
using a method described previously by our laboratory and
others.9,10,14,15,29–33 At second passage, 100,000 cells of
each cell line were seeded in a single T-75 flask in CGM
comprised of alpha-modified minimal essential medium (a-
MEM with l-glutamine; Invitrogen, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (FBS, Premium Select;
Atlanta Biologicals, Lawrenceville GA), 200 mM l-glutamine,
and 100 IU penicillin/100 mg/mL streptomycin (Mediatech,
Herndon, VA). The cells were allowed to proliferate at 37C
in 5% carbon dioxide until reaching 80% confluency, and
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then passaged. The amassed cells were then characterized
for osteogenic and adipogenic potential, ensuring that the
cells differentiated representative of an average of the five
cell lines.15
Pellet culture
After the third passage, hASCs were resuspended at a
density of 250,000 cells per pellet. Cells were centrifuged at
300 g for 5 min to allow a pellet to form at the bottom of the
tube. Pellets were cultured in 1 mL of selected chondrogenic
differentiation medium (CDM) at either basal levels of Ca2 +
(1.8 mM) or elevated Ca2 + (8 mM) concentration.9 Calcium
concentration was elevated by dissolving CaCl2 (Sigma, St.
Louis, MO) in the culture medium. Chondrogenic differ-
entiation media were changed every 48 h by removing
0.5 mL of the media and replacing with fresh media.
Characterization of chondrogenic medium
Pellets were cultured in one of six CDM formulations
(Table 1). All six chondrogenic media were primarily
comprised of Dulbecco’s modified Eagle’s medium (Med-
iatech), 1% dexamethasone (Sigma), 1% ITS+ (Sigma), 1%
Pen/Strep, and 1% ascorbic acid (Sigma), with vary-
ing combinations of FBS, bone morphogenetic protein 6
(BMP6), and transforming growth factor b1 (TGF-b1), as
outlined in Table 1. Pellets were cultured at 37C in 5%
carbon dioxide for 28 days, receiving conditioned media
changes every 48 h, by removing and replacing half of the
media to preserve growth factors secreted by the cells. As-
corbic acid and chondrogenic growth factors, TGF-b1 and
BMP6, were added to each medium formulation immedi-
ately before conditioned media changes. Cell pellets were
then dehydrated, paraffin embedded, and sectioned for his-
tological analyses. Sections were stained with Alcian blue
(Sigma) to analyze glycosaminoglycan (GAG) content, as
well as immunohistochemical (IHC) staining for collagen
type II. IHC was conducted with a Histostain-Plus Kit (In-
vitrogen) utilizing primary antibodies for collagen type II
(II-II6B; DSHB, IOWA city, IA). Pellet cultures grown




Pellets from each condition were collected after 28 days
of culture for quantitative reverse transcriptase–polymerase
chain reaction (RT-PCR) analyses. Total RNA from three
pellets per condition were homogenized and resuspended in
TRIzol reagent (Invitrogen) following the manufacturer’s
instructions. The mRNA concentration and purity were de-
termined using a NanoDrop spectrophotometer (Thermo
Scientific, Wilmington, DE). The RNA was reverse-tran-
scribed using SuperScript III First-Strand Synthesis System
for qRT-PCR with oligo (dT) primers kit (Invitrogen) and
amplified using an ABI Prism 7000 system (Applied Bio-
systems, Carlsbad, CA). The amplified PCR product was
detected using SYBR Green reagents (Life Technologies,
Grand Island, NY), with primer-specific amplification per-
formed at 60C for 30 s, and fluorescent quantification
performed at 72C. Each analysis was performed in trip-
licate. The following primers were designed using the
Integrated DNA Technologies website: Aggrecan forward
5¢-CAGGCAGATCACTTGAGGTTAG-3¢ reverse 5¢-CTC
CCTAGTAGCTGGGATTACA-3¢; collagen I forward 5¢-
AGAGTGGAGCAGTGGTTACTA-3¢ reverse 5¢-GATAC
AGGTTTCGCCAGTAGAG-3¢; collagen II forward 5¢-TG
GCCCTCAAGGATTTCAAG-3¢ reverse 5¢-ACCATCATC
ACCAGGCTTTC-3¢; Runx2 forward 5¢-CATCACTGTC
CTTTGGGAGTAG-3¢ reverse 5¢-ATGTCAAAGGCTGT
CTGTAGG-3¢; b-actin forward 5¢-CACTCTTCCAGCCT
TCCTTC-3¢ reverse 5¢-GTACAGGTCTTTGCGGATGT-3¢.
Signals were normalized to b-actin expression levels using
the -DDCT method.34
Statistical analyses
Statistical analyses were performed using IBM SPSS
software (version 22; IBM, Armonk, NY). A paired t-test for
each gene was performed to determine the statistical sig-
nificance between the two groups. p-Values below 0.05
were considered statistically significant.
Fabrication of nanofibrous scaffolds
Biodegradable, biocompatible PLA (molecular weight of
70,000 g/mol) was dissolved in chloroform and dimethyl-
formamide (Sigma) at a ratio of 3:1 to create a 12% solution.
The solution was mixed continuously at 80C for 12 h. The
PLA solution was electrospun immediately after preparation
at a feed rate of 0.7 mL/h using 15 kV, and regular single-
component nanofibrous scaffolds were collected on a static
collector spaced about 15 cm from the tip of the needle.
Scaffolds were cut into squares of 1 · 1 cm2. The nanofibrous
scaffolds were then needle-punched (30 pores/layer) to create
micron-sized pores with a pore diameter of 300mm.
Construction of stacked scaffolds
PLA scaffolds were sterilized in 70% ethanol for 10 min
and rinsed with phosphate-buffered saline three times before
culturing cells on the scaffolds. Scaffolds were then placed
in 24-well plates and soaked in CGM for 12 h. Human ASC
(passage 3) were seeded at 250,000 cells/cm2 on PLA na-
nofibers with 0% TCP and 20,000 cells/cm2 on 20% TCP-
loaded nanofibers, then cultured in 100 mL of CGM. After




2 No FBS, TGF-b1 (10 ng/mL)
3 No FBS, TGF-b1 (10 ng/mL),
BMP6 (10 ng/mL)
4 10% FBS
5 10% FBS, TGF-b1 (10 ng/mL)
6 10% FBS, TGF-b1 (10 ng/mL),
BMP6 (10 ng/mL)
Six different media conditions were evaluated to optimize pellet
growth conditions. All formulations were comprised of Dulbecco’s
modified Eagle’s medium, 1% dexamethasone, 1% ITS + , 1% Pen/
Strep, and 1% ascorbic acid. Only FBS and chondrogenic factors
TGF-b1 and BMP6 varied among formulations.
BMP6, bone morphogenetic protein 6; FBS, fetal bovine serum;
TGF-b1, transforming growth factor-b1.
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hASC-seeded nanofibrous scaffolds were incubated for 3 h
to allow cells to adhere, the five layers were then stacked
together using type I collagen gel at a concentration of 3 mg/
mL (Vitrogen; Angiotech BioMaterials Corporation, Palo
Alto, CA).10 Collagen I was first neutralized to pH 7.0 with
1 N NaOH, and 100 mL pipetted between the layers. The
stacked constructs were incubated for 2 h to allow the col-
lagen gel to polymerize, and then transferred to new 24-well
plates with 1 mL culture medium. The constructs were
cultured for 7 days in CGM, with medium changes every 3
days. After 7 days, CGM was replaced with CDM and
scaffolds remained in this medium for the remaining 3
weeks, with conditioned medium change every 3 days, for a
total culture time of 28 days.
Histological analyses
After 28 days in culture, pellets from elevated 8 mM
Ca2 + conditions, pellets from basal 1.8 mM Ca2 + condi-
tions, and stacked scaffolds were collected for histological
analyses. Samples were fixed in 10% buffered formalin for
24 h, dehydrated with a graded series of ethanol, embedded
in paraffin blocks, and sectioned in 10 mm (pellets) or 6 mm
(stacked scaffolds)-thick slices. Sections were stained with
Safranin O (Thermo Fisher, Waltham, MA) or Alcian blue
to assess GAG content, and with Alizarin red to evaluate
cell-mediated calcium accretion. Histochemical staining for
collagen expression was conducted using primary antibodies
for collagen II (Abcam #3092, Cambridge, UK), collagen I
(Abcam #90395), and collagen X (Sigma #c7974) and a
horseradish peroxidase detection system (DAB Substrate
Kit; Vector Laboratories, Burlingmae, CA) following the
manufacturer’s instructions. Collagen I immunohistochem-
istry was performed using a primary collagen I antibody
(1:100 dilution; Abcam #90395) followed by an Alexa Fluor
488 goat anti-mouse IgG (1:200 dilution; Life Technologies,
Carlsbad, CA) secondary antibody. Images were captured
using a Leica EZ4 D Digital Steremicroscope (Leica
Microsystems, Inc., Buffalo Grove, IL) equipped with a
40 · water immersion, high-resolution camera (Hamamatsu,
Hamamatsu, Japan), and SimplePCI image capture and
analysis software (Compix, Sewickley, PA).
Scanning electron microscopy analysis
Field emission scanning electron microscopy (FESEM
JEOL 6400 F) was used to characterize the surface mor-
phology and microstructure of the ultrafine electrospun fi-
bers at 15 kV accelerating voltage.
Results
Optimization of chondrogenic differentiation media
To optimize hASC chondrogenic differentiation, pellets
were grown in six different formulations of CDM (Table 1),
and analyzed for sulfated GAG content and collagen II ex-
pression. Pellets grown in the absence of 10% FBS, 10 ng/
mL of BMP6, and 10 ng/mL of TGF-b1 (formulation 1)
were negative for collagen II and GAG expression, and were
unable to form a solid pellet. Similarly, pellets grown in
TGF-b1 but no FBS or BMP6 (formulation 2) did not form a
compact pellet, but showed light expression of GAGs to-
ward the center of the forming pellet. Pellets grown in both
chondrogenic growth factors without FBS (formulation 3)
exhibited a solid center, but loose periphery along the pellet,
and very low GAG and collagen II expression. Pellets
grown with FBS but in the absence of both chondrogenic
factors (formulation 4) were able to form a round and solid
pellet, but showed scattered GAG and collagen II expres-
sion. Pellets grown in FBS and TGF-b1 but no BMP6
(formulation 5), exhibited a solid and round pellet mor-
phology, but less GAG and collagen II expression when
compared to CDM containing FBS and both chondrogenic
factors (formulation 6, data not shown).
Our results indicated that the presence of FBS in the
media was crucial for the formation of a round and compact
pellet, and that both TGF-b1 and BMP6 were necessary
for improved chondrogenic differentiation, as expected.35
Based on this data, formulation 6 was chosen for all further
experiments.
Immunohistological analyses of pellets
cultured in varied calcium conditions
Human ASC pellets cultured in the same CDM but varied
Ca2 + concentrations underwent dissimilar differentiation
pathways. Morphologically, pellets cultured in the basal
Ca2 + concentration (1.8 mM) formed round and compact
pellets when compared to pellets cultured in elevated Ca2 +
(8 mM) conditions. The outer peripheries of pellets cultured
in 8 mM Ca2 + appeared stratified and loose, whereas control
pellets cultured in basal 1.8 mM Ca2 + were uniformly dense
and compact (Fig. 1). Additionally, pellets cultured in ele-
vated Ca2 + conditions (8 mM) exhibited significant tissue
mineralization as assessed by positive Alizarin red staining
(Fig. 1B). After 28 days of culture in CDM, pellets grown in
elevated Ca2 + (8 mM) mineralized, with more pronounced
mineralization in the outer periphery, in closer proximity to
the elevated Ca2 + in the medium. In contrast, pellets cul-
tured in basal Ca2 + conditions (1.8 mM) were negative for
Alizarin red staining and only showed fast green counter-
stain (Fig. 1A).
GAG content was also greater in pellets cultured in basal
Ca2 + conditions (1.8 mM) suggesting greater chondrogenic
differentiation when compared to pellets cultured with the
same CDM, but at elevated Ca2 + concentration (8 mM) as
assessed by Safranin O and Alcian blue stains (Fig. 1C–H).
Higher magnification of the center of the pellets stained with
Alcian blue indicate that hASC pellets cultured in 1.8 mM
Ca2 + concentration exhibit a more chondrocyte-like phe-
notype (cells with lacunae) as compared to the more oste-
oblast-like phenotype for hASC cultured in elevated 8 mM
Ca2 + conditions (Fig. 1G, H).
IHC analyses indicated that hASC cultured in 8 mM Ca2 +
exhibited greater collagen type I and X expressions and less
collagen type II expression than control hASC cultured in
1.8 mM Ca2 + (Fig. 2). Negative control pellets were ob-
tained performing DAB (3,3¢-diaminobenzidine) staining in
the absence of a primary antibody (Fig. 2A, B). Location of
collagen expression also varied within the experimental and
control hASC pellets. In the 8 mM Ca2 + pellets, positive
staining for collagen type I was more prevalent in the loose
outer periphery of the pellets, whereas positive staining
within the basal calcium pellets was more uniform throughout
the pellet, with the exception of some negative staining
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FIG. 1. Changes in tissue mineralization and glycosaminoglycan (GAG) production in response to different calcium
concentrations. (A, B) Alizarin red staining (fast green counterstain) of pellet cultures of human adipose-derived stem cells
cultured in chondrogenic differentiation medium (CDM) and elevated calcium (8 mM) shows excess tissue mineralization
(B), most notable in the outer periphery of pellet when compared to basal calcium (1.8 mM) conditions (A). (C, D) Safranin
O staining of pellet cultures in basal calcium (1.8 mM) shows increased GAG production (C) when compared to elevated
calcium (8 mM) concentrations (D). (E, F) Alcian blue/Hematoxylin staining of pellet cultures in basal calcium (1.8 mM)
(E) and elevated calcium (8 mM) is similar, but closer view of the pellets shows that cells in 1.8 mM calcium have a more
chondrocyte-like morphology (G) when compared to the 8 mM cells showing a more fibroblast-like morphology (H) (Black
scale bars = 100mm; yellow scale bars = 25 mm). Color images available online at www.liebertpub.com/tea
FIG. 2. Immunohistochemistry of human adipose-derived stem cell pellets cultured under different calcium concentra-
tions. Pellets grown in CDM containing transforming growth factor-b1 (TGF-b1) and bone morphogenetic protein 6
(BMP6) at basal (1.8 mM) or elevated (8 mM) calcium concentrations were stained for (C, D) collagen I, (E, F) collagen II,
and (G, H) collagen X. (A, B) Control pellets with no primary antibody and (scale bar = 100mm). Color images available
online at www.liebertpub.com/tea
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toward the middle of the pellet (Fig. 2C, D). Control 1.8 mM
Ca2 + pellets also exhibited greater collagen type II expres-
sion relative to pellets cultured in elevated Ca2 + (8 mM)
conditions (Fig. 2E, F). Although both 1.8 and 8 mM Ca2 +
pellets exhibited positive staining for collagen type X within
the center of each section, elevated Ca2 + (8 mM) pellets had
stronger collagen type X staining in the loose outer periphery
relative to the controls, suggesting a possible zone of hy-
pertrophy in elevated Ca2 + conditions (Fig. 2G, H).
Changes in gene expression in pellets cultured
under different calcium concentrations
To further assess hASC differentiation in pellets cultured
in CDM at different Ca2 + concentrations, gene expression
was analyzed in both conditions. Consistent with the his-
tological findings, pellets cultured in elevated Ca2 + (8 mM)
exhibited a significant increase in collagen I ( p = 0.038) and
Runx2 ( p = 0.136), and decreased synthesis of collagen II
( p = 0.0003) and aggrecan mRNA expression ( p = 0.013)
when compared to the basal calcium (1.8 mM) control cells
(Fig. 3).
Analyses of osteochondral constructs
SEM analyses confirmed that electrospun nanofibers were
successfully loaded with TCP nanoparticles. Surface mor-
phology analyses of the fibers confirmed the presence of
TCP in the nanofibers (Fig. 4). The PLA electrospun layers
were then stacked using two layers of 20% TCP-PLA
scaffolds and three layers of 0% TCP-PLA scaffolds to
generate a representative osteochondral scaffold (Fig. 5A,
D). The electrospun layers were needle-punched before
stacking to allow cell infiltration throughout the layers after
the complete, stacked construct was created (Fig. 5B, C). To
inhibit released TCP from the bottom layers affecting cells
residing in the 0% TCP layers, media were changed every
other day. This approach, in combination with the known
precipitation of calcium downward (due to gravity) as op-
posed to upward, appeared successful.
Specifically, consistent with our hypothesis and pellet
data, hASC differentiated in a site-specific manner in re-
sponse to TCP concentrations to generate bone in the bottom
FIG. 3. Changes in gene expression of hASC pellets
cultured in elevated calcium relative to pellets cultured in
basal calcium conditions. Pellets grown in CDM containing
TGF-b1 and BMP6 at elevated (8 mM) calcium concentra-
tions exhibited increased collagen I and Runx2 mRNA ex-
pression, and decreased collagen II and aggrecan mRNA
expression relative to those cultured in basal calcium
(1.8 mM) conditions (dashed line) as assessed by quantita-
tive reverse transcriptase–polymerase chain reaction. All
data were normalized to b-actin (*p-value < 0.05).
FIG. 4. Scanning electron microscopy of
electrospun polylactic acid (PLA) fibers
used to seed human adipose-derived stem
cells. Top panel shows pure PLA fibers (0%
tricalcium phosphate [TCP]) and bottom
panel shows PLA fibers containing 20%
TCP concentration.
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layers (20% TCP) and cartilage in the top layers (0% TCP)
when cultured for 1 week in CGM followed by culture for
3 weeks in CDM containing TGF-b1 and BMP-6. Hema-
toxylin and eosin staining shows successful cell migration
throughout the needle-punched nanofibrous PLA layers
(Fig. 6A). Alizarin red staining of the stacked scaffold
shows increased tissue mineralization in the bottom layers
containing 20% TCP when compared to the superficial layers
(Fig. 6B). Alcian blue staining shows increased chon-
drogenesis in the 0% TCP superficial layers when compared
to the deep 20% TCP layers (Fig. 6C). Immunofluorescence
of collagen I staining shows increased collagen I expression
in the bottom layers containing 20% TCP when compared
to the superficial layers with no TCP (Fig. 6D).
Discussion
The goal of this study was to investigate the effects of
extracellular Ca2 + concentration on hASC chondrogenesis
and the potential to use controlled Ca2 + delivery to induce
site-specific chondrogenesis and osteogenesis using hASC
seeded in a single scaffold. Our results supported our hy-
pothesis that elevated Ca2 + inhibits hASC chondrogenesis
and induces a differentiation phenotype representing a
combination of both hASC osteogenesis and chondrogen-
esis, when cultured in optimal chondrogenic differentiation
conditions. Histological analyses demonstrated clear dif-
ferences between pellets cultured in basal 1.8 mM and ele-
vated 8 mM Ca2 + concentrations, most notably in tissue
mineralization and changes in collagen I, II, and X ex-
pressions. Morphologically, hASC pellets cultured in 8 mM
Ca2 + exhibited loose and stratified layers toward the outer
periphery of the pellet, as opposed to the round and com-
pact uniform morphology of control pellets. Immunohis-
tochemistry results for collagen X expression indicated
enhanced collagen X staining within the loose peripheral
layers of the elevated Ca2 + pellets.
Collagen X is associated with chondrocyte hypertrophy
and ossification as well as calcified cartilage, where bone
and cartilage tissue interact. These results suggest that cells
in the outside of the pellet may have become hypertrophic
and possibly undergoing endochondral ossification. This is
consistent with previous studies showing the role of PTHrP
in inhibiting hypertrophy in chondrocytes.36–39 Parathyroid
hormone-related protein is downregulated in environments
of high Ca2 + concentration due to signaling through the
extracellular calcium sensing receptor.5,37 Increased PTHrP
has been associated with increased chondrocyte proliferation
and maintenance of cells in a matrix-forming phenotype,
resulting in increased matrix production.36,37
Histological findings also demonstrated that both 8 and
1.8 mM Ca2 + pellets differentiated down the chondrogenic
lineage, but to varying degrees. Safranin-O staining showed
both conditions stained positive for sulfated GAGs, but
pellets cultured in 1.8 mM Ca2 + exhibited greater positive
staining than pellets cultured in 8 mM Ca2 + . These quali-
tative findings were further supported by changes in gene
expression as assessed by quantitative RT-PCR analyses.
After 28 days in culture, pellets in 8 mM Ca2 + expressed
significant increases in collagen I, and decreased collagen II
and aggrecan expression when compared to pellets cultured
in 1.8 mM Ca2 + , suggesting that elevated 8 mM Ca2 +
FIG. 5. Construction of stacked osteochondral constructs. (A) Schematic image of different layers in stacked os-
teochondral construct showing how the electrospun PLA nanofibers (blue layers) were stacked together using collagen I gel
(red layers) in between nanofibrous layers to form the stacked construct. The top three layers were pure PLA (0% TCP) to
allow chondrogenesis, and the bottom two layers contained 20% TCP to inhibit chondrogenesis and induce osteogenesis. (B,
C) Light microscopy images of nanofibers with needle-punched pores; (D) image of a stacked construct containing three
layers of pure PLA fibers and two layers 20% TCP-PLA fibers. Color images available online at www.liebertpub.com/tea
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induced osteogenesis, regardless of the optimal culture
conditions to induce chondrogenesis.
In addition to the histological and IHC analyses for
chondrogenic markers, further analyses were performed to
determine the effects of elevated 8 mM Ca2 + on osteogenic
differentiation of hASC cultured in CDM. Pellets in 8 mM
Ca2 + exhibited positive Alizarin red staining throughout the
pellet, but more pronounced in the outer periphery, which
was in closer contact to the elevated Ca2 + in the media. In
contrast, pellets cultured in basal Ca2 + (1.8 mM) conditions
were all negative for Alizarin red staining. Immunohis-
tochemistry for collagen I showed that both control and
experimental pellets stained positively, but in different lo-
cations. In 8 mM Ca2 + sections, positive IHC staining was
mostly localized to the loose outer layers of the pellet,
whereas the 1.8 mM Ca2 + pellets demonstrated positive
collagen I staining in a swirled pattern in the center of the
pellet.
The mechanisms responsible for these positive results are
not clear and require further study. However, we suspect
that the calcium sensing receptor (CaSR) may play a role in
inhibiting chondrogenesis in response to increased extra-
cellular calcium, as it has been shown to be expressed and
functionally active in osteoblast-like cell lines40 and several
types of stem cells, including human and ovine amniotic
fluid stem cells,41 equine umbilical cord matrix,42 and bone
marrow mesenchymal stem cells (MSCs).43 More recently,
the calcium-sensing receptor was reported to play a potential
role in the osteogenic differentiation of human amniotic
fluid MSCs.44
This study demonstrates that culturing hASC in CDM at
elevated 8 mM Ca2 + concentration results in inhibited
hASC chondrogenesis. While chondrogenic differentiation
can occur to some extent, the cells in closest contact to the
elevated Ca2 + environment, toward the outer portions of the
pellet, appear to become hypertrophic, and possibly undergo
endochondral ossification. Additionally, this process de-
creases the production of cartilage extracellular matrix
components. These differences in cell morphology and ex-
tracellular matrix production may be indicative of varying
mechanical properties within the pellet and this should be
further studied. These data are promising for further os-
teochondral tissue engineering studies using hASC as a
single cell source to produce both bone and articular carti-
lage by simply modulating Ca2 + concentrations.
As a first step on this path, we used a multilayered fab-
rication approach for local delivery of extracellular calcium
to hASC to regulate site-specific osteogenesis and chon-
drogenesis. Generation of osteochondral tissue-engineered
grafts requires an integrated combination of articular carti-
lage and bone tissue regeneration to mimic native osteo-
chondral tissue.45 Traditionally, chondrogenic and osteoblastic
cell lines have been used as a source for osteochondral re-
generation, but the limited supply and regenerative cap-
abilities of primary cells can present a challenge for tissue
regeneration. Therefore, the use of stem cells as an alter-
native resource is very promising.46–48
Although many investigators have successfully generated
cartilage and bone tissue using stem cells, a remaining
challenge is the generation of osteochondral tissue with
cartilaginous and bone-like regions using a single stem cell
source. Further, recreating the interphase between the car-
tilage and subchondral bone has been the most difficult
challenge in successful osteochondral tissue engineering.
This osteochondral junction consists of calcified cartilage,
and has a critical mechanical and physiological role, acting
as a biochemical barrier and mechanical transition between
the soft cartilage and stiff subchondral bone.49 Therefore,
FIG. 6. Histochemical staining of stacked PLA scaffolds containing 0% or 20% TCP seeded with human adipose-derived
stem cells (hASC) for 28 days. (A) Hematoxylin and eosin staining showing cells growing in all layers. Dark lines between
stacks show regions of highest cell density where hASC were seeded on nanofibrous PLA or PLA/TCP scaffolds before
stacking within collagen gel. (B) Alizarin red staining showing calcium accretion (red) in the 20% TCP-loaded nanofibers
and none in 0% TCP-loaded nanofibers. (C) Alcian blue staining showing increased hASC chondrogenesis in top three
layers (0% TCP). (D) Immunofluorescence for collagen I shows increased expression in the bottom 20% TCP layers when
compared to the superficial 0% layers. Color images available online at www.liebertpub.com/tea
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such scaffolds must consist of a gradient or differential re-
lease of cytokines and/or growth factors to induce site-
specific differentiation.
A popular approach for developing successful osteo-
chondral tissue is using biphasic constructs, designed to
induce bone formation in the deep layer and cartilage in the
top layer.50 Some researchers have attempted to develop
barriers between the two layers to prevent infiltration of
blood vessels into the cartilage tissue.51,52 Although sepa-
ration of the cartilage and bone tissues may be achieved,
the mechanical properties of the two phases and integration
of the two scaffolds into one construct present significant
challenges, and lack a transitional zone between the two
phases. A more recent approach to develop a full osteo-
chondral construct used a dual growth factor delivery ap-
proach, for a spatially guided formation of osteochondral
tissue.53 Although most of these studies have successfully
formed bone, cartilage, or both, the transitional interphase
between the cartilage and subchondral bone that mimics
both mechanically and biochemically the interphase of os-
teochondral tissue, remains a challenge.
Our technique of layering multiple nanofibrous scaffolds
that differentially release extracellular calcium to induce
hASC site-specific chondrogenesis and osteogenesis holds
great potential for developing a full osteochondral construct.
Nanofibers have morphological similarities to collagen na-
nofibers within the extracellular matrix of native tissue. Col-
lagen nanofibers play an important role in maintaining the
structural integrity of various tissues, including bone and
cartilage.54 We have previously shown that hASC attach and
proliferate well on PLA nanofibers.10,16,17 We also have ex-
tensive experience with incorporating TCP nanoparticles, an
osteoconductive drug, in nanofibers and assessing their release
profile and subsequent effect on hASC differentiation.10,16
According to our previous results, electrospun single
component PLA nanofibers containing 20% TCP have a
burst release profile releasing about 50% of calcium ions in
the first day followed by the gradual release of the re-
maining calcium in the following days up to 36 days.16
Although incorporating TCP particles in the PLA nanofibers
increases the fiber diameter, we have previously shown that
the change in fiber diameter does not have a negative effect
on cell viability or proliferation of hASC.10 Our previous
results confirmed that hASC cultured in CGM on 20%
TCP in single component PLA nanofibers differentiate down
an osteogenic pathway. In this study, hASC also underwent
osteogenic differentiation, as confirmed by Alizarin red
staining, in a combination of CGM and chondrogenic
growth medium when cultured in the 20% TCP/PLA bottom
layers of the osteochondral scaffolds to successfully form
a subchondral bone region. Cells seeded on pure PLA
(0% TCP) nanofibers differentiated down the chondrogenic
pathway. This suggests that the release of calcium ions from
nanofibers not only induces osteogenesis, but also inhibits
chondrogenesis in the presence of CDM, consistent with our
findings from the pellet studies.
Conclusions
Our study reports the effects of elevated calcium on
hASC chondrogenesis, and shows that extracellular Ca2 +
can induce osteogenesis of hASC, even when cultured in
optimal chondrogenic differentiation conditions. Our results
show that hASC is able to chondrogenically differentiate in
basal calcium conditions (1.8 mM); however, chondrogen-
esis is inhibited to a significant degree in elevated 8 mM
Ca2 + conditions as shown by decreased matrix production
and increased mineralization of the tissue. The potential use
of regulated calcium release in designing osteochondral
constructs was evaluated by developing a multilayer stacked
nanofibrous construct with regional incorporation of TCP
nanoparticles. This technique enabled differentiation of both
cartilage and bone tissue in one continuous construct using
only hASC as a single cell source. Further investigation to
determine the material properties of the resulting tissue and
the possible underlying mechanism(s) that modulate hASC
differentiation in response to calcium concentrations are
being investigated.
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